AVH 2.29% $2.99 avita medical inc.

Investors want Recell to hit earnings guidance for the year....

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,473 Posts.
    lightbulb Created with Sketch. 327
    Investors want Recell to hit earnings guidance for the year. There's a high chance that Avita won't hit it. That would equal another guidance revision and another 40% drop in SP. After a couple of guidance failures with earnings and another guidance failure with Recell Go in September, investors are tired of the crap. It's debatable that the SP could go down AFTER Go approval if the guidance isn't met.
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.